gene_symbol
C1QA
hgnc_id
HGNC:1241
binding_type
receptor ligand recognition
cytotoxicity
NO
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
Naxitamab targets GD2 on tumor cells, inducing ADCC/ADCP and CDC (via C1q binding to the antibody Fc) to lyse GD2+ cells; it does not target or kill C1q-expressing cells.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
Initiates complement-dependent cytotoxicity (CDC) via binding IgG1 Fc; heterotrimer with C1QB/C1QC
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06574698
disease_id_num_tar_ref
546
drug_id_num_tar_ref
1505